Table 1.

Comparison of dosage and administration schedule before and after the introduction of the collaborative system

Compliance status	Pre-introduction (n=820)	Post-introduction (n=1495)	P value
Recommended dosage and administration schedule	441 (53.8%)	1189 (79.5%)	<.001 a
Non-recommended dosage and administration schedule
Single dose less than the recommended	255 (31.1%)	132 (8.8%)	<.001 a
Single dose more than the recommended	34 (4.1%)	58 (3.9%)	.740
Dosing interval shorter than recommended	48 (5.9%)	71 (4.7%)	.279
Dosing interval longer than recommended	42 (5.1%)	44 (2.9%)	.011 a
Total	379 (46.2%)	305 (20.4%)	<.001 a

^a P < 0.05.